Personalized Cannabinoid and/or Terpene Extract Compositions with Enhanced Bioavailability

This inventive concept envisions a next-generation system for generating personalized cannabinoid and/or terpene extract compositions with tunable bioavailability, leveraging advanced data processing, solvent selection, emulsifier optimization, and nanoparticle carrier systems to revolutionize the field of cannabinoid-based therapies.

The original patent disclosed a water-soluble, powdered cannabinoid and/or terpene extract, but it had limitations in terms of bioavailability and personalized dosing. The new inventive concept addresses these limitations by introducing a modular, automated system capable of producing a range of extract compositions with varying bioavailability profiles, tailored to individual biometric data.

The inventive concept comprises a data processing unit that analyzes individual biometric data to determine the optimal cannabinoid and/or terpene extract composition. A solvent selection module and an emulsifier optimization module work in tandem to solubilize and emulsify the extract, respectively. The resulting emulsified extract is then lyophilized to form a powder with adjustable particle size and surface area, allowing for tunable bioavailability. A nanoparticle carrier system can be integrated to enable targeted delivery of the extract to specific tissues or organs. The system can be monitored and optimized in real-time using spectroscopic techniques and a database of known bioavailability profiles.

The new claims introduce a paradigm shift in the field of cannabinoid-based therapies by enabling personalized, data-driven extract compositions with enhanced bioavailability. The inventive concept's novelty lies in the integration of advanced data processing, solvent selection, emulsifier optimization, and nanoparticle carrier systems to create a modular, automated system capable of producing a range of extract compositions with varying bioavailability profiles.

Alternative embodiments of the inventive concept could include the use of machine learning algorithms to predict optimal extract compositions based on individual biometric data, or the integration of additional modules for real-time monitoring of extract composition bioavailability. Variations of the inventive concept could also include the use of different solvent selection modules or emulsifier optimization modules to accommodate various extract compositions and bioavailability profiles.

The inventive concept has significant commercial potential in the pharmaceutical, nutraceutical, and wellness industries, where personalized cannabinoid-based therapies are increasingly in demand. The system's ability to produce a range of extract compositions with varying bioavailability profiles could revolutionize the treatment of various diseases and disorders, including chronic pain, inflammation, and anxiety disorders.